Edwards Lifesciences (EW) Share-based Compensation (2009 - 2026)
Edwards Lifesciences (EW) posted quarterly Share-based Compensation of $45.4 million for Q1 2026, up 12.94% year-over-year from $40.2 million in Q1 2025, and up 15.82% quarter-over-quarter from $39.2 million in Q4 2025.
Edwards Lifesciences (EW) Share-based Compensation (2009 - 2026) Analysis & Trends
Edwards Lifesciences' Share-based Compensation history runs 18 years deep, the most recent figure standing at $45.4 million for Q1 2026.
- In Q1 2026, Share-based Compensation rose 12.94% year-over-year to $45.4 million; the TTM figure through Mar 2026 stood at $163.3 million (up 3.42% YoY), while the FY2025 annual figure was $158.1 million, down 2.59% from the prior year.
- Share-based Compensation for Q1 2026 stood at $45.4 million, up from $39.2 million in the prior quarter.
- The five-year high for Share-based Compensation was $45.4 million in Q1 2026, with the low at $27.9 million in Q4 2022.
- The 5-year median for Share-based Compensation is $37.5 million (2025), against an average of $37.2 million.
- The sharpest annual moves came in 2024 and 2025: Share-based Compensation advanced 29.14% in 2024, then slipped 14.58% in 2025.
- Edwards Lifesciences' Share-based Compensation stood at $27.9 million in 2022, then advanced by 9.32% to $30.5 million in 2023, then advanced by 3.93% to $31.7 million in 2024, then grew by 23.66% to $39.2 million in 2025, then increased by 15.82% to $45.4 million in 2026.
- Business Quant data shows EW's Share-based Compensation at $45.4 million in Q1 2026, $39.2 million in Q4 2025, and $41.2 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.20 Bn | 193.60 Bn | 7.27 Bn | 168.00 Mn |
| 2 | Stryker | 127.66 Bn | 124.19 Bn | 4.50 Bn | 7.00 Mn |
| 3 | Medtronic | 118.98 Bn | 109.76 Bn | 6.41 Bn | 95.00 Mn |
| 4 | Boston Scientific | 73.25 Bn | 72.71 Bn | 3.85 Bn | 87.00 Mn |
| 5 | Edwards Lifesciences | 51.93 Bn | 47.68 Bn | 1.35 Bn | 42.20 Mn |
| 6 | Dexcom | 34.37 Bn | 32.42 Bn | 830.00 Mn | 39.00 Mn |
| 7 | GE HealthCare Technologies | 33.89 Bn | 31.78 Bn | 2.18 Bn | 45.00 Mn |
| 8 | Koninklijke Philips | 26.36 Bn | 23.04 Bn | 4.55 Bn | 94.15 Mn |
| 9 | Steris | 23.03 Bn | 22.55 Bn | 684.20 Mn | 12.80 Mn |
| 10 | Zimmer Biomet Holdings | 19.20 Bn | 18.79 Bn | 1.54 Bn | 23.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 42.20 Mn |
| Jun 30, 2026 | 42.20 Mn |
| Mar 31, 2026 | 45.40 Mn |
| Mar 31, 2026 | 45.40 Mn |
| Dec 31, 2025 | 39.20 Mn |
| Dec 31, 2025 | 39.20 Mn |
| Sep 30, 2025 | 41.20 Mn |
| Sep 30, 2025 | 41.20 Mn |
| Jun 30, 2025 | 37.50 Mn |
| Jun 30, 2025 | 37.50 Mn |
| Mar 31, 2025 | 40.20 Mn |
| Mar 31, 2025 | 40.20 Mn |
| Dec 31, 2024 | 31.70 Mn |
| Dec 31, 2024 | 31.70 Mn |
| Sep 30, 2024 | 42.10 Mn |
| Sep 30, 2024 | 42.10 Mn |
| Jun 30, 2024 | 43.90 Mn |
| Jun 30, 2024 | 43.90 Mn |
| Mar 31, 2024 | 44.60 Mn |
| Mar 31, 2024 | 44.60 Mn |